7Senger DR, Van de Water L, Brown LF, et al. Vascular permeability factor (VPF, VEGF) in tumor biology[J]. Cancer Metastasis Rev, 1993,12(3-4) : 303-324. 被引量：1
8Funatsu H, Yamashita H, Nakamura S, et al. Vitreous levels of pigment, epithelium-derived factor and vascular endothelial growth factor are related to diabetic macular edema [J]. Ophthalmology, 2006 ; 113 (2) : 294-301. 被引量：1
9Isbida S, Usui T, Yamashiro K, et al. VEGF164 is proinflammatory in the diabetic retina[J]. Invest Ophthalmol Vis Sci, 2003,44(5) : 2155-2162. 被引量：1
10Cohen AF, Van Bronswijk H. New medications:bevacizumab[J]. Ned Tijdschr Geneeskd,2006,150(40):2194-2195. 被引量：1
4Fukus AM. Classi ficat ion and t reatmen t of diab et ic ret in- opath-y[J]. Diabetic Res CI in Pract, 1994,24 : 171-176. 被引量：1
5Sander B, Larsen M, Moldow B, et al. Diabetic edema: Passive andaetive transport of fluorescein through the blood-retina bar- rier[J]. Invest Ophthalmol Vis Sci,2001,42(2):433-438. 被引量：1
6Blumenkranz MS. Optimal current and future treatments for diabetic macular edema[J]. Eye, 2010,24 (3) : 428-434. 被引量：1
7Bakri SJ, Beer PM. The effect of intravitreal triamcinolone acetonide on intraoeular pressure[J]. Opthalmic Surg Laser Imaging, 2003,34: 390. 被引量：1
8Smiddy WE, Hynn HW. Vitrectomy in the management of diabetic etinopathy[J]. Surv Ophthalmol, 1999,43 : 491. 被引量：1
